HL-A ANTIGENS IN MYASTHENIA GRAVIS
- 16 February 1974
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 303 (7851) , 240-243
- https://doi.org/10.1016/s0140-6736(74)92548-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- SLOWLY ABSORBED L-DOPA PREPARATION IN THE TREATMENT OF PARKINSONISMActa Neurologica Scandinavica, 2009
- SUSTAINED-RELEASE LEVODOPA IN PARKINSONISMThe Lancet, 1973
- Metabolism of 3, 4-dihydroxyphenylalanine by isolated perfused rat liverBiochemical Pharmacology, 1971
- Demethylation of 3-O-methyldopa in the ratLife Sciences, 1971
- Degradation of DOPA by Intestinal Microorganisms in VitroActa Pharmacologica et Toxicologica, 1971
- Minor Urinary Metabolites of L‐Dopa in the RatActa Pharmacologica et Toxicologica, 1971
- m-Hydroxyphenylacetic Acid Formation from L-Dopa in Man: Suppression by NeomycinScience, 1969
- Drug Metabolism by Intestinal MicroorganismsJournal of Pharmaceutical Sciences, 1968
- Metabolism of Phenolic Acids by the Rat Intestinal MicrofloraActa Pharmacologica et Toxicologica, 1968
- 4-methylcatechol, a metabolite of homoprotocatechuic acidCellular and Molecular Life Sciences, 1967